[1] Chen WQ, Zheng RS, Baade PD, Zhang SW, Zeng HM, Bray F, et al. Cancer statistics in China, 2015. CA: A Cancer J Clin 2016;66(2):115 − 32. http://dx.doi.org/10.3322/caac.21338CrossRef
[2] GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1736 − 88. http://dx.doi.org/10.1016/S0140-6736(18)32203-7CrossRef
[3] Chen WQ, Xia CF, Zheng RS, Zhou MG, Lin CQ, Zeng HM, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. Lancet Glob Health 2019;7(2):e257 − 69. http://dx.doi.org/10.1016/S2214-109X(18)30488-1CrossRef
[4] Liu SW, Wu XL, Lopez AD, Wang LJ, Cai Y, Page A, et al. An integrated national mortality surveillance system for death registration and mortality surveillance, China. Bull World Health Organ 2016;94(1):46 − 57. http://dx.doi.org/10.2471/BLT.15.153148CrossRef
[5] National Health Commission, Chinese Center for Disease Control and Prevention. China mortality surveillance yearbook, 2018. Beijing: China Science and Technology Press, 1st ed, 2019. (In Chinese)
[6] National Data. Tabulation on the 2010 population census of the People’s Republic of China. [2020-01-18]. http://data.stats.gov.cn/.http://data.stats.gov.cn/
[7] Guo K, Yin P, Wang LJ, Ji YB, Li QF, Bishai D, et al. Propensity score weighting for addressing under-reporting in mortality surveillance: a proof-of-concept study using the nationally representative mortality data in China. Popul Health Metr 2015;13:16. http://dx.doi.org/10.1186/s12963-015-0051-3CrossRef
[8] Chen WQ, Sun KX, Zheng RS, Zeng HM, Zhang SW, Xia CF, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res 2018;30(1):1 − 12. http://dx.doi.org/10.21147/j.issn.1000-9604.2018.01.01CrossRef
[9] Wang JB, Jiang Y, Liang H, Li P, Xiao HJ, Ji J, et al. Attributable causes of cancer in China. Ann Oncol 2012;23(11):2983 − 9. http://dx.doi.org/10.1093/annonc/mds139CrossRef
[10] Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA 2014;311(2):183 − 92. http://dx.doi.org/10.1001/jama.2013.284692CrossRef
[11] Global Burden of Disease 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392(10159):1923 − 94. http://dx.doi.org/10.1016/S0140-6736(18)32225-6CrossRef
[12] Chen WQ, Zheng RS, Zhang SW, Zeng HM, Xia CF, Zuo TT, et al. Cancer incidence and mortality in China, 2013. Cancer Lett 2017;401:63 − 71. http://dx.doi.org/10.1016/j.canlet.2017.04.024CrossRef
[13] Chen WQ, Zheng RS, Zuo TT, Zeng HM, Zhang SW, He J. National cancer incidence and mortality in China, 2012. Chin J Cancer Res 2018;28(1):1 − 11. http://dx.doi.org/10.3978/j.issn.1000-9604.2016.02.08CrossRef
[14] Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol 2019;5(12):1749 − 68. http://dx.doi.org/10.1001/jamaoncol.2019.2996CrossRef